𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase 1/2 of a combination of Cetuximab and Taxane for “triple negative” breast cancer patients

✍ Scribed by Nechushtan, Hovav; Vainer, Gilad; Stainberg, Hana; Salmon, Asher Y.; Hamburger, Tamar; Peretz, Tamar


Book ID
122251842
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
977 KB
Volume
23
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES